vs

Side-by-side financial comparison of Dexcom (DXCM) and Life Time Group Holdings, Inc. (LTH). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $745.1M, roughly 1.7× Life Time Group Holdings, Inc.). Dexcom runs the higher net margin — 21.2% vs 16.5%, a 4.7% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 12.3%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 11.7%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Life Time Group Holdings, Inc. operates a network of premium athletic, fitness and wellness destinations across the United States. It offers diverse services including state-of-the-art gym facilities, group exercise classes, personal training, spa treatments, nutrition coaching, youth programs and co-working spaces for consumers pursuing holistic healthy lifestyles.

DXCM vs LTH — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.7× larger
DXCM
$1.3B
$745.1M
LTH
Growing faster (revenue YoY)
DXCM
DXCM
+9.2% gap
DXCM
21.6%
12.3%
LTH
Higher net margin
DXCM
DXCM
4.7% more per $
DXCM
21.2%
16.5%
LTH
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
11.7%
LTH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
LTH
LTH
Revenue
$1.3B
$745.1M
Net Profit
$267.3M
$123.0M
Gross Margin
62.9%
49.1%
Operating Margin
25.6%
17.4%
Net Margin
21.2%
16.5%
Revenue YoY
21.6%
12.3%
Net Profit YoY
153.6%
231.0%
EPS (diluted)
$0.67
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
LTH
LTH
Q1 26
$1.3B
Q4 25
$1.3B
$745.1M
Q3 25
$1.2B
$782.6M
Q2 25
$1.2B
$761.5M
Q1 25
$1.0B
$706.0M
Q4 24
$1.1B
$663.3M
Q3 24
$994.2M
$693.2M
Q2 24
$1.0B
$667.8M
Net Profit
DXCM
DXCM
LTH
LTH
Q1 26
$267.3M
Q4 25
$267.3M
$123.0M
Q3 25
$283.8M
$102.4M
Q2 25
$179.8M
$72.1M
Q1 25
$105.4M
$76.1M
Q4 24
$151.7M
$37.2M
Q3 24
$134.6M
$41.4M
Q2 24
$143.5M
$52.8M
Gross Margin
DXCM
DXCM
LTH
LTH
Q1 26
62.9%
Q4 25
62.9%
49.1%
Q3 25
60.5%
47.1%
Q2 25
59.5%
47.0%
Q1 25
56.9%
47.5%
Q4 24
58.9%
48.2%
Q3 24
59.7%
46.5%
Q2 24
62.4%
46.8%
Operating Margin
DXCM
DXCM
LTH
LTH
Q1 26
25.6%
Q4 25
25.6%
17.4%
Q3 25
20.1%
17.3%
Q2 25
18.4%
14.2%
Q1 25
12.9%
15.2%
Q4 24
17.0%
13.1%
Q3 24
15.3%
13.5%
Q2 24
15.7%
15.7%
Net Margin
DXCM
DXCM
LTH
LTH
Q1 26
21.2%
Q4 25
21.2%
16.5%
Q3 25
23.5%
13.1%
Q2 25
15.5%
9.5%
Q1 25
10.2%
10.8%
Q4 24
13.6%
5.6%
Q3 24
13.5%
6.0%
Q2 24
14.3%
7.9%
EPS (diluted)
DXCM
DXCM
LTH
LTH
Q1 26
$0.67
Q4 25
$0.67
$0.55
Q3 25
$0.70
$0.45
Q2 25
$0.45
$0.32
Q1 25
$0.27
$0.34
Q4 24
$0.37
$0.17
Q3 24
$0.34
$0.19
Q2 24
$0.35
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
LTH
LTH
Cash + ST InvestmentsLiquidity on hand
$917.7M
$204.8M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$2.7B
$3.1B
Total Assets
$6.3B
$8.0B
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
LTH
LTH
Q1 26
$917.7M
Q4 25
$917.7M
$204.8M
Q3 25
$1.8B
$218.9M
Q2 25
$1.2B
$175.5M
Q1 25
$904.9M
$59.0M
Q4 24
$606.1M
$10.9M
Q3 24
$621.2M
$120.9M
Q2 24
$939.2M
$34.5M
Total Debt
DXCM
DXCM
LTH
LTH
Q1 26
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.7B
Q2 24
$1.8B
Stockholders' Equity
DXCM
DXCM
LTH
LTH
Q1 26
$2.7B
Q4 25
$2.7B
$3.1B
Q3 25
$2.7B
$3.0B
Q2 25
$2.6B
$2.9B
Q1 25
$2.3B
$2.7B
Q4 24
$2.1B
$2.6B
Q3 24
$2.0B
$2.6B
Q2 24
$2.4B
$2.4B
Total Assets
DXCM
DXCM
LTH
LTH
Q1 26
$6.3B
Q4 25
$6.3B
$8.0B
Q3 25
$7.5B
$7.8B
Q2 25
$7.3B
$7.6B
Q1 25
$6.8B
$7.3B
Q4 24
$6.5B
$7.2B
Q3 24
$6.4B
$7.2B
Q2 24
$6.8B
$7.1B
Debt / Equity
DXCM
DXCM
LTH
LTH
Q1 26
Q4 25
0.48×
Q3 25
0.51×
Q2 25
0.53×
Q1 25
0.56×
Q4 24
0.59×
Q3 24
0.64×
Q2 24
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
LTH
LTH
Operating Cash FlowLast quarter
$239.9M
Free Cash FlowOCF − Capex
$-64.6M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
40.9%
Cash ConversionOCF / Net Profit
1.95×
TTM Free Cash FlowTrailing 4 quarters
$-21.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
LTH
LTH
Q1 26
Q4 25
$294.0M
$239.9M
Q3 25
$659.9M
$251.1M
Q2 25
$303.0M
$195.7M
Q1 25
$183.8M
$183.9M
Q4 24
$301.4M
$163.1M
Q3 24
$199.5M
$151.1M
Q2 24
$279.4M
$170.4M
Free Cash Flow
DXCM
DXCM
LTH
LTH
Q1 26
Q4 25
$192.1M
$-64.6M
Q3 25
$579.4M
$28.6M
Q2 25
$208.9M
$-26.3M
Q1 25
$96.8M
$41.4M
Q4 24
$176.8M
$26.8M
Q3 24
$88.3M
$64.0M
Q2 24
$213.3M
$26.1M
FCF Margin
DXCM
DXCM
LTH
LTH
Q1 26
Q4 25
15.3%
-8.7%
Q3 25
47.9%
3.7%
Q2 25
18.1%
-3.5%
Q1 25
9.3%
5.9%
Q4 24
15.9%
4.0%
Q3 24
8.9%
9.2%
Q2 24
21.2%
3.9%
Capex Intensity
DXCM
DXCM
LTH
LTH
Q1 26
Q4 25
8.1%
40.9%
Q3 25
6.7%
28.4%
Q2 25
8.1%
29.2%
Q1 25
8.4%
20.2%
Q4 24
11.2%
20.6%
Q3 24
11.2%
12.6%
Q2 24
6.6%
21.6%
Cash Conversion
DXCM
DXCM
LTH
LTH
Q1 26
Q4 25
1.10×
1.95×
Q3 25
2.33×
2.45×
Q2 25
1.69×
2.71×
Q1 25
1.74×
2.41×
Q4 24
1.99×
4.39×
Q3 24
1.48×
3.65×
Q2 24
1.95×
3.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

LTH
LTH

Membership$535.1M72%
In Center$191.2M26%
Other$18.8M3%

Related Comparisons